| Enriched cancer pathway | Genes under regulation | P value |
|---|
| Adipocytokine signaling pathway |
3 genes: LEP, PPARA, PRKAA2
|
0.0005827 |
| MAPK signaling pathway |
4 genes: MAPT, NFATC2, PRKCA, TAOK1
|
0.003862 |
| Natural killer cell mediated cytotoxicity |
3 genes: NFATC2, SHC3, PRKCA
|
0.004254 |
| Focal adhesion |
3 genes: SHC3, PRKCA, TLN2
|
0.01225 |
| VEGF signaling pathway |
2 genes: NFATC2, PRKCA
|
0.01436 |
| Phosphatidylinositol signaling system |
2 genes: PRKCA, PIP4K2B
|
0.01508 |
| ErbB signaling pathway |
2 genes: SHC3, PRKCA
|
0.01854 |
| Salivary secretion |
2 genes: ATP2B4, PRKCA
|
0.01934 |
| Pancreatic secretion |
2 genes: ATP2B4, PRKCA
|
0.0245 |
| Vascular smooth muscle contraction |
2 genes: PPP1R12B, PRKCA
|
0.03163 |
| Selenocompound metabolism |
1 genes: MTR
|
0.04004 |
| Renin.angiotensin system |
1 genes: ACE
|
0.04004 |
| One carbon pool by folate |
1 genes: MTR
|
0.04235 |
| Insulin signaling pathway |
2 genes: SHC3, PRKAA2
|
0.04337 |